These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35793037)

  • 1. "Cutting the Mustard" with Induced Pluripotent Stem Cells: An Overview and Applications in Healthcare Paradigm.
    Behl T; Kaur I; Sehgal A; Singh S; Sharma N; Chigurupati S; Felemban SG; Alsubayiel AM; Iqbal MS; Bhatia S; Al-Harrasi A; Bungau S; Mostafavi E
    Stem Cell Rev Rep; 2022 Dec; 18(8):2757-2780. PubMed ID: 35793037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
    Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
    Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
    Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
    Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells in companion animals: how can we move the field forward?
    Barrachina L; Arshaghi TE; O'Brien A; Ivanovska A; Barry F
    Front Vet Sci; 2023; 10():1176772. PubMed ID: 37180067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.
    Pushp P; Nogueira DES; Rodrigues CAV; Ferreira FC; Cabral JMS; Gupta MK
    Stem Cell Rev Rep; 2021 Jun; 17(3):748-776. PubMed ID: 33098306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
    Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
    J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical templates for tissue (re)generation and beyond.
    Mavaro I; De Felice E; Palladino A; D'Angelo L; de Girolamo P; Attanasio C
    Biotechnol Bioeng; 2020 Dec; 117(12):3938-3951. PubMed ID: 32776516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.
    Ray A; Joshi JM; Sundaravadivelu PK; Raina K; Lenka N; Kaveeshwar V; Thummer RP
    Stem Cell Rev Rep; 2021 Dec; 17(6):1954-1974. PubMed ID: 34100193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cells as a new source of induced pluripotent stem cells.
    Shamsian A; Sahebnasagh R; Norouzy A; Hussein SH; Ghahremani MH; Azizi Z
    Stem Cell Res Ther; 2022 Sep; 13(1):459. PubMed ID: 36064437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
    Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
    Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
    [No Abstract]   [Full Text] [Related]  

  • 17. Human induced pluripotent stem cells--from mechanisms to clinical applications.
    Drews K; Jozefczuk J; Prigione A; Adjaye J
    J Mol Med (Berl); 2012 Jul; 90(7):735-45. PubMed ID: 22643868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced Pluripotency: A Powerful Tool for In Vitro Modeling.
    Zahumenska R; Nosal V; Smolar M; Okajcekova T; Skovierova H; Strnadel J; Halasova E
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
    Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
    J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.